612 results on '"Minghetti, Paola"'
Search Results
2. Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence
3. Equivalence assessment of creams with quali-quantitative differences in light of the EMA and FDA regulatory framework
4. Regulatory Aspects and Barriers in Using Groundbreaking Technologies
5. Patient-managed digital medical devices: Do we need further regulation?
6. Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System
7. Pediatricians’ awareness of galenic drugs for children with special needs: a regional survey
8. Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union
9. Cases of drug repositioning in children's orphan drugs: Licenced drugs versus unlicenced magistral preparations
10. Regulatory Aspects and Barriers in Using Groundbreaking Technologies
11. Medicinal products meet medical devices: Classification and nomenclature issues arising from their combined use
12. Extended-release calcifediol in stage 3–4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D
13. Printing of cutaneous patches loaded with propranolol for the treatment of infantile haemangiomas
14. Stability of high concentrated triple intrathecal therapy for pediatrics and mitigation strategies
15. Pharmaceutical Expenditure: Aspects of Cost Containment in Italy
16. Medicinal products, medical devices, or accessories of medical devices: How to qualify gases for spirometry?
17. Old active ingredients in new medicinal products: is the regulatory path coherent with patients’ expectations?
18. Updating ‘Data on the determination of human epidermis integrity in skin permeation experiments by electrical resistance’ with Data on pig ear skin
19. Chapter 14 - Regulatory aspects of 3D printing systems in healthcare
20. Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies
21. Lysozyme Mucoadhesive Tablets Obtained by Freeze-Drying
22. Glatiramer acetate: A complex drug beyond biologics
23. β-galactosidase orodispersible dosage forms for the treatment of lactose intolerance
24. Β-Galactosidase Orodispersible Dosage Forms for the Treatment of Lactose Intolerance
25. Drug-in-micelles-in-liposomes (DiMiL) systems as a novel approach to prevent drug leakage from deformable liposomes
26. Copies of nonbiological complex drugs: generic, hybrid or biosimilar?
27. Design of in vitro skin permeation studies according to the EMA guideline on quality of transdermal patches
28. The use of an acellular matrix derived from human dermis for the treatment of full-thickness skin wounds
29. Poly(methyl methacrylate) salt as film forming material to design orodispersible films
30. Orodispersible dosage forms: biopharmaceutical improvements and regulatory requirements
31. Tuning the rheological properties of an ammonium methacrylate copolymer for the design of adhesives suitable for transdermal patches
32. In vitro method to evaluate the barrier properties of medical devices for cutaneous use
33. Molecular Dynamics as a tool for in silico screening of skin permeability
34. Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?
35. Emulsion versus nanoemulsion: how much is the formulative shift critical for a cosmetic product?
36. Feeding Next‐Generation Nanomedicines to Europe: Regulatory and Quality Challenges
37. Nonionic Surfactants: Polyethylene Glycol (PEG) Ethers and Fatty Acid Esters as Penetration Enhancers
38. Pharmaceutical Pricing Policies in Italy
39. Nanofiller for the mechanical reinforcement of maltodextrins orodispersible films
40. Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence
41. Contributors
42. Nature of the Interaction of Alpha-D-Mannose and Escherichia coli Bacteria, and Implications for Its Regulatory Classification. A Delphi Panel European Consensus Based on Chemistry and Legal Evidence
43. Digital Technologies Applied to Control the One-Step Process of Cannabis Olive Oil Preparations
44. New trends in drug delivery: The contribution of young European researchers
45. The anatomical therapeutic chemical classification is flexible enough to describe the innovation in biotechnological drugs?
46. Regulatory framework of pharmaceutical compounding and actual developments of legislation in Europe
47. List of Contributors
48. Economic Evaluation and Medicines Expenditure in Developing Countries
49. Medicinal products, medical devices, or accessories of medical devices: How to qualify gases for spirometry?
50. Ultrasound-Assisted Extraction of Cannabinoids from Cannabis Sativa for Medicinal Purpose
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.